Advantages and Challenges of PRM in Low-Abundance Protein Quantification
- Biomarker validation in disease research (e.g., early-stage cancers and neurodegenerative disorders)
- Dynamic target monitoring in pharmacodynamic evaluation and mechanistic studies
- Standardized PRM analysis in multi-center clinical cohorts
In proteomics research, accurate low-abundance protein quantification is essential for early biomarker discovery, drug target validation, and the elucidation of complex signaling pathways. However, conventional data-dependent acquisition (DDA) approaches often exhibit limited sensitivity and poor reproducibility when applied to complex biological matrices and extremely low-abundance targets. In recent years, Parallel Reaction Monitoring (PRM) has attracted increasing attention for targeted quantification of low-abundance proteins due to its high selectivity, reproducibility, and throughput. This article provides a systematic analysis of the technical advantages and practical challenges of PRM in low-abundance protein detection, and summarizes the application experience and technical platform of MtoZ Biolabs in this field.
PRM Technology: Evolution from SRM to PRM
PRM is a high-resolution targeted mass spectrometry technique developed from traditional Selected Reaction Monitoring (SRM/MRM). Its core principle involves monitoring all fragment ions of selected target peptides on high-resolution mass spectrometers, such as Orbitrap or TOF platforms, thereby enhancing quantitative accuracy and specificity.
Advantages and Challenges of PRM Technology in Low-Abundance Protein Quantification
PRM is a targeted quantification strategy based on high-resolution mass spectrometry platforms (e.g., Orbitrap). In a typical workflow, predefined precursor ions are selected via LC-MS, followed by full-scan acquisition of all corresponding product ions. During data processing, representative fragment ions can be selected post-acquisition for quantification, improving both methodological flexibility and analytical specificity.
1. Key Advantages
(1) High Resolution and Mass Accuracy: Orbitrap systems provide ppm-level mass accuracy, significantly enhancing the confidence of target ion identification.
(2) No Requirement for Predefined Transitions: Unlike SRM, PRM allows post-acquisition selection of fragment ions, improving analytical depth and robustness in low-abundance protein quantification.
(3) Compatibility with Complex Matrices: High selectivity reduces background interference, making PRM particularly suitable for high dynamic range samples such as plasma and cerebrospinal fluid.
2. Several Technical Challenges of PRM in Low-Abundance Protein Quantification
(1) Limited Detectability of Target Peptides: Certain peptides exhibit low ionization efficiency and are prone to matrix suppression, resulting in unstable or weak signals.
(2) Interference from Complex Sample Backgrounds: The wide dynamic range of protein concentrations in biological samples (e.g., spanning up to 12 orders of magnitude in plasma) can obscure signals from low-abundance targets.
(3) Constraints in Reproducibility and Linear Dynamic Range: Achieving consistent quantification at sub-femtomole levels across batches and samples requires highly optimized analytical conditions and stringent quality control.
(4) Complexity of Data Analysis: Although platforms such as Skyline provide robust visualization, accurate data interpretation still depends on experienced analysts, particularly in the presence of significant background interference.
MtoZ Biolabs integrates the Orbitrap Exploris 480 high-resolution mass spectrometry platform with optimized targeted proteomics workflows to deliver sensitive, accurate, and reproducible PRM quantification services for both research and clinical applications. The platform encompasses end-to-end capabilities, including target design, method development, sample preparation, and data analysis. Specifically, high-sensitivity PRM workflows have been developed for low-abundance protein analysis, supporting applications such as:
PRM technology provides a powerful solution for the high-sensitivity quantification of low-abundance proteins and demonstrates significant potential in biomarker validation and preclinical research. With the continued integration of advanced mass spectrometry platforms and data analysis algorithms, PRM is expected to play an increasingly important role in precision medicine. MtoZ Biolabs remains committed to advancing the application of PRM technologies and supporting innovation in life science research.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
